FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971292292> ?p ?o ?g. }

• W1971292292 endingPage "364" @default.
• W1971292292 startingPage "358" @default.
• W1971292292 abstract "The purpose of this study was to determine the toxicity and efficacy of single daily fractionation as compared with twice-a-day radiation therapy in combination with chemotherapy for preoperative locally advanced thoracic esophageal carcinoma. A retrospective survey was done of 42 patients undergoing concurrent chemotherapy and radiation for preoperative locally advanced thoracic esophageal carcinoma. Twenty-five patients had 5-fluorouracil ([5-FU]), 1,000 mg/m2/d by continuous infusion, days 1-5, and days 22-26), cisplatin (100 mg/m2 intravenously, days 2 and 22), and radiation to a total dose of 4,500 to 5,040 cGy in 180 cGy/fraction every day. Seventeen patients received 5-FU (300 mg/m2/d by continuous infusion, days 1 and 21), cisplatin (20 mg/m2/d for 1 hour, days 1-5 and days 17-20), vinblastine (1 mg/m2 intravenously, days 1-5 and days 17-21) and accelerated hyperfractionated radiation 150 cGy twice a day to a total dose of 4,500 cGy. Response rate, survival, local regional failure rates, and treatment toxicity of the two groups were compared. Surgery was aborted in one patient and another patient refused surgery in the single daily-fractionation group. All patients underwent surgery in the twice-daily group. Complete response (CR) was noted in 12 patients (52%) in the single daily-fractionation group as compared with 9 patients (52%) in the twice-daily group. The median and 3-year survival were 20 months and 35%, respectively, in the single daily-fractionation group. Corresponding figures were 18 months and 32%, respectively, in the twice-daily group. For the 2 groups combined, a statistically significant improvement in survival was observed among blacks who achieved a CR (31 months) as compared with the ones with residual disease (13.5 months). Local and regional failures were 28% and 17%, respectively, for the single daily-fractionation and twice-daily groups. Distant metastases remained significant in both groups and were 36% (single daily-fractionation) and 41% (twice-daily), respectively. Grades III to IV esophagitis and hematologic toxicity developed in 36% and 64% of patients of the single daily-fractionation and twice-daily groups, respectively. The incidence of late complications was 16% (single daily-fractionation) and 11.7% (twice-daily). Preoperative chemotherapy and radiation is effective to achieve a high pathologic CR. Both radiation therapy fractionation schedules are comparable in efficacy and toxicity. Further investigations should be done to assess whether ethnicity may play a role in the prognosis of esophageal carcinoma." @default.
• W1971292292 created "2016-06-24" @default.
• W1971292292 creator A5011421542 @default.
• W1971292292 creator A5012327557 @default.
• W1971292292 creator A5012630601 @default.
• W1971292292 creator A5020947443 @default.
• W1971292292 creator A5024166341 @default.
• W1971292292 creator A5025699897 @default.
• W1971292292 creator A5052104524 @default.
• W1971292292 creator A5058390627 @default.
• W1971292292 creator A5061169832 @default.
• W1971292292 creator A5061491447 @default.
• W1971292292 creator A5072543782 @default.
• W1971292292 creator A5082050220 @default.
• W1971292292 date "2002-08-01" @default.
• W1971292292 modified "2023-09-26" @default.
• W1971292292 title "Preoperative Chemotherapy and Radiation for Advanced Esophageal Carcinoma" @default.
• W1971292292 cites W1901180305 @default.
• W1971292292 cites W1904805820 @default.
• W1971292292 cites W1921758104 @default.
• W1971292292 cites W1963889504 @default.
• W1971292292 cites W1977468182 @default.
• W1971292292 cites W2012039688 @default.
• W1971292292 cites W2015899464 @default.
• W1971292292 cites W2024086237 @default.
• W1971292292 cites W2030617355 @default.
• W1971292292 cites W2032792368 @default.
• W1971292292 cites W2055631922 @default.
• W1971292292 cites W2063241896 @default.
• W1971292292 cites W2079266794 @default.
• W1971292292 cites W2111414124 @default.
• W1971292292 cites W2115460631 @default.
• W1971292292 cites W2123927174 @default.
• W1971292292 cites W2136594231 @default.
• W1971292292 cites W2144263975 @default.
• W1971292292 cites W2178272638 @default.
• W1971292292 cites W2333224485 @default.
• W1971292292 cites W2412204324 @default.
• W1971292292 cites W50448417 @default.
• W1971292292 doi "https://doi.org/10.1097/00000421-200208000-00008" @default.
• W1971292292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12151965" @default.
• W1971292292 hasPublicationYear "2002" @default.
• W1971292292 type Work @default.
• W1971292292 sameAs 1971292292 @default.
• W1971292292 citedByCount "5" @default.
• W1971292292 countsByYear W19712922922012 @default.
• W1971292292 countsByYear W19712922922013 @default.
• W1971292292 countsByYear W19712922922017 @default.
• W1971292292 crossrefType "journal-article" @default.
• W1971292292 hasAuthorship W1971292292A5011421542 @default.
• W1971292292 hasAuthorship W1971292292A5012327557 @default.
• W1971292292 hasAuthorship W1971292292A5012630601 @default.
• W1971292292 hasAuthorship W1971292292A5020947443 @default.
• W1971292292 hasAuthorship W1971292292A5024166341 @default.
• W1971292292 hasAuthorship W1971292292A5025699897 @default.
• W1971292292 hasAuthorship W1971292292A5052104524 @default.
• W1971292292 hasAuthorship W1971292292A5058390627 @default.
• W1971292292 hasAuthorship W1971292292A5061169832 @default.
• W1971292292 hasAuthorship W1971292292A5061491447 @default.
• W1971292292 hasAuthorship W1971292292A5072543782 @default.
• W1971292292 hasAuthorship W1971292292A5082050220 @default.
• W1971292292 hasConcept C126322002 @default.
• W1971292292 hasConcept C126894567 @default.
• W1971292292 hasConcept C141071460 @default.
• W1971292292 hasConcept C155806632 @default.
• W1971292292 hasConcept C2776694085 @default.
• W1971292292 hasConcept C2777132456 @default.
• W1971292292 hasConcept C2777546739 @default.
• W1971292292 hasConcept C2778239845 @default.
• W1971292292 hasConcept C509974204 @default.
• W1971292292 hasConcept C71924100 @default.
• W1971292292 hasConceptScore W1971292292C126322002 @default.
• W1971292292 hasConceptScore W1971292292C126894567 @default.
• W1971292292 hasConceptScore W1971292292C141071460 @default.
• W1971292292 hasConceptScore W1971292292C155806632 @default.
• W1971292292 hasConceptScore W1971292292C2776694085 @default.
• W1971292292 hasConceptScore W1971292292C2777132456 @default.
• W1971292292 hasConceptScore W1971292292C2777546739 @default.
• W1971292292 hasConceptScore W1971292292C2778239845 @default.
• W1971292292 hasConceptScore W1971292292C509974204 @default.
• W1971292292 hasConceptScore W1971292292C71924100 @default.
• W1971292292 hasIssue "4" @default.
• W1971292292 hasLocation W19712922921 @default.
• W1971292292 hasLocation W19712922922 @default.
• W1971292292 hasOpenAccess W1971292292 @default.
• W1971292292 hasPrimaryLocation W19712922921 @default.
• W1971292292 hasRelatedWork W1956400930 @default.
• W1971292292 hasRelatedWork W1986335982 @default.
• W1971292292 hasRelatedWork W2093185281 @default.
• W1971292292 hasRelatedWork W2381952599 @default.
• W1971292292 hasRelatedWork W2408650435 @default.
• W1971292292 hasRelatedWork W2409259941 @default.
• W1971292292 hasRelatedWork W2412908548 @default.
• W1971292292 hasRelatedWork W2431556937 @default.
• W1971292292 hasRelatedWork W2987293068 @default.
• W1971292292 hasRelatedWork W2130708671 @default.
• W1971292292 hasVolume "25" @default.
• W1971292292 isParatext "false" @default.

• next